16.35 Form: Term Sheet for Series C Preferred Stock
The following term sheet sets forth the terms and conditions of Series C
preferred stock to be purchased in a private company by a strategic investor.
The term sheet assumes that the private company has previously issued Series A
and Series B preferred stock. The terms are very similar to those that would
apply if the investment were being made by a venture capital investor.
SERIES [C] CONVERTIBLE PREFERRED STOCK TERM SHEET
______________________, 2003The intent of this term sheet (the "Term Sheet") is to describe, for
negotiation purposes only, some key terms of a possible investment in certain
equity securities of [Company Name] (the "Company"). This document is not, and
shall not be construed to be, a binding agreement between any person or entity
and the Company with respect to the subject matter hereof, except for the
following paragraph regarding confidentiality. A binding agreement will not
occur unless and until all necessary corporate approvals have been obtained and
the parties have negotiated, approved, executed and delivered the appropriate
definitive agreements. Until execution and delivery of such definitive
agreements, the Company and any potential investor, including any person who is
provided a copy of this Term Sheet, shall have the absolute right to terminate
all negotiations for any reason or no reason without liability therefor. Confidentiality
The terms and conditions described in this Term Sheet, including its
existence, shall be confidential information and shall not be disclosed by any
person or entity who receives a copy of this Term Sheet to any other person or
entity. By accepting a copy of this Term Sheet, you agree to comply with the
provisions of this paragraph. If any person or entity determines that it is
required by law to disclose the existence of this Term Sheet or any information
contained herein, or to provide a copy of this Term Sheet to any governmental
entity or regulatory authority, it shall, a reasonable time before taking any
such action, consult with the Company regarding such action and seek
confidential treatment for such portions as may be requested by the Company. Terms
Issuer: [Name], a [Delaware] Corp.
Investor: [strategic corporate investor]
Total Amount of Financing: Up to $_______________
Type of Security: Up to [insert number] shares of Series [C] Preferred Stock
("Series [C] Preferred"), initially convertible into an equal number of shares
of the Company's common stock (the "Common Stock")
Closing: On or before ___________
Pre-Money Valuation: [$_______ million]
Purchaser Price Per Share: $_____ per share of Series [C] Preferred.
The Purchase Price has been calculated by dividing (1) the pre-money
valuation by (2) the fully diluted amount of Common Stock and "common stock
equivalents" expected to be outstanding immediately before closing, including:
(a) All issued and outstanding shares of Common Stock;
(b) All issued and outstanding shares of Preferred Stock
(excluding the Series [C] Preferred);
(c) Shares issuable upon exercise of all outstanding options and
warrants to purchase any such Common or Preferred Stock;
(d) Shares issuable upon exercise of all options reserved for
future awards under the Company's stock incentive plan; and
(e) Any other outstanding commitments, contingent or otherwise, to
issue shares, options or warrants, including any and all senior securities or
obligations convertible into Common Stock or Preferred Stock and any warrants
granted to vendors or strategic partners.
Rights and Preferences of Series [C] Preferred:
Dividend Rights: The Series [C] Preferred would be entitled to an annual per
share dividend equal to [__%] of the Purchase Price, payable when and if
declared by the Board of Directors (the "Board"). The dividends would be
[non]cumulative and would be paid prior to payment of any dividend with respect
to the Common Stock [and any [existing or future] other series of Preferred
Stock]. After payment of the preferential dividend to the holders of the Series
[C] Preferred [and any other series of preferred stock], any further dividends
would be paid pari passu to the holders of the Series [C] Preferred, [the other
series of Preferred Stock] and the Common Stock on a pro rata, as-converted
basis. The Series [C] Preferred also would be entitled to receive pari passu
with the holders described immediately above any noncash dividends declared by
the Board on a pro rata, as-converted basis. [Note: A cumulative dividend is one that accrues over time even if not
declared by the Board. When the Board ultimately declares a dividend or upon
liquidation (including a change of control event), the holder is entitled to all
of the accrued dividends whether or not declared, if the dividends are
cumulative. See "Liquidation Preference" below.]
Liquidation Preference: In the event of any liquidation, dissolution or winding
up of the Company, the holders of the Series [C] Preferred would be entitled to
receive, prior to any distribution to the holders of the Common Stock [or any
other series of Preferred Stock], an amount equal to [___ times] the Purchase
Price, plus all [declared but unpaid][accrued but unpaid, whether or not
declared] dividends thereon (the "Preference Amount"). After the full
liquidation preference on all outstanding shares of Series [C] Preferred [and
the other series of preferred stock] has been paid, any remaining funds and
assets of the Company legally available for distribution to stockholders would
be distributed pari passu among the holders of the Series [C] Preferred, [other
series of preferred stock] and the Common Stock on a pro rata, as-converted
basis[; provided, however, that the maximum amount to be paid per share of
Series [C] Preferred would in no event exceed [insert multiple or rate of
return]. If the Company had insufficient assets to permit payment of the
Preference Amount in full to all Series [C] Preferred holders, then the assets
of the Company would be distributed ratably to the holders of the Series [C]
Preferred in proportion to the Preference Amount each such holder would
otherwise be entitled to receive.A merger, acquisition, change of control, consolidation or other
transaction or series of transactions in which the Company's stockholders prior
to such transaction or transactions would not retain a majority of the voting
power of the surviving entity, or a sale of all or substantially all the
Company's assets, would be deemed to be a liquidation, dissolution or winding up
of the Company for purposes of the liquidation preference. [Note: The liquidation preference formula raises a number of issues that
are heavily negotiated. In the case of preferred stock that is not
participating, the investors must choose between converting to common or
receiving their liquidation preference. In the case of participating preferred,
the investors need not make a choice. They receive their preference and then
share the balance with the common on an as-converted basis. The formula for the
liquidation preference can have several structures: (1) amount paid, plus
declared but unpaid dividends; (2) amount paid, plus a cumulative dividend from
the date of issuance, whether or not declared; (3) a multiple (e.g., 1.5x, 2.0x,
3.0x) of the original purchase price; and (4) a combination of (1) and (3), or
(2) and (3). If the preferred is participating, it is not unusual for the
preferred holders to be subject to an upside cap at some multiple of the
original amount invested or a specified rate of return from the date of issuance.]
Redemption: Subject to any legal restrictions on the Company's redemption of
shares, at any time after [Insert date], the holders of a majority of the then
outstanding Series [C] Preferred may require the Company to redeem the
outstanding Series [C] Preferred. The redemption price for each share of Series
[C] Preferred would be [insert appropriate formula] of the Purchase Price, plus
all declared but unpaid dividends thereon to the date of redemption (the
"Redemption Price"). The Redemption Price would be proportionally adjusted for
stock splits, stock dividends, etc. If, on the redemption date, the number of
shares of Series [C] Preferred that may then be legally redeemed by the Company
is less than the number of such shares to be redeemed, then the shares to be
redeemed but that may not be legally redeemed would be redeemed as soon as the
Company had legally available funds therefore.
Conversion Rights: The holders of the Series [C] Preferred would have the right
to convert the Series [C] Preferred into shares of Common Stock at any time. The
initial conversion rate for the Series [C] Preferred would be one-for-one.
Automatic Conversion: The Series [C] Preferred would automatically convert into
Common Stock, at the then-applicable conversion rate, upon the closing of a
firmly underwritten public offering of shares of Common Stock of the Company
pursuant to a registration statement on Form S-1 under the Securities Act of
1933, for listing on a [inter]nationally recognized exchange, at an effective
public offering price of at least [$____] per share and gross proceeds to the
Company in excess of [$________ million] (a "Qualified IPO"). [Note: The Qualified IPO amount is typically a multiple of the preferred
issuance price.] The Series [C] Preferred would also automatically convert into Common
Stock, at the then-applicable conversion rate, upon approval of the holders of
[a majority][66 2/3%] of the outstanding shares of Series [C] Preferred.
Antidilution Provisions: The conversion price of the Series [C] Preferred would
be subject to adjustment on a [full-ratchet] [broad-based weighted
average][narrow-based weighted average] basis for issuances at a purchase price
less than the then-effective conversion price with a carve-out for issuances of
(1) shares upon conversion, exchange and/or exercise of securities outstanding
on the date of the closing or issued after such date but permitted by Clauses
(2) through (5); (2) stock option or other incentive awards to employees,
consultants and directors[ involving up to [insert number] shares of Common
Stock] (3) shares of Common Stock, or warrants or other securities exercisable
or exchangeable for, or convertible into, such shares, to equipment or other
lessors, financial institutions or other lenders in connection with commercial
credit arrangements, real estate leases, equipment leases or other similar
financings; (4) equity securities pursuant to the acquisition by the Company of
another business entity, products or technologies; and (5) shares of Common
Stock, or warrants or other securities exercisable or exchangeable for, or
convertible into, such shares, to suppliers, customers or other strategic
partners, provided, however, that each such event described in clauses (2)
through (5) is approved by a majority of the Board.[Note: The three types of antidilution price protection are, (1) full
ratchet; (2) broad-based weighted average and (3) narrow-based weighted average.
A full ratchet adjusts the conversion price downwards to the price of securities
issued subsequent to the preferred round. An issuer can make strong arguments
that full-ratchet dilution overcompensates the preferred. When financing
conditions are difficult, however, investors may insist on full-ratchet
protection. A broad-based weighted average, sometimes described as only weighted
average or fully diluted, is the most common type of price based antidilution
protection. It takes into account the actual economic dilution based on the size
of round and the issuance price. "Fully diluted" means that, when calculating
the dilution, the number of shares outstanding, pre-round, includes shares
issuable pursuant to outstanding options, warrants and other common stock
equivalents, but not shares reserved for issuance upon future awards of options
under incentive plans. It is to the company's advantage to make the definition
of the number of shares outstanding, pre-issuance, as large as possible because
it reduces the dilution adjustment. The "narrow-based weighted average" formula
is similar to the broad-based weighted average formula, but excludes the impact
of outstanding options and warrants.]
Voting Rights: Each share of Series [C] Preferred would carry a number of votes
equal to the number of shares of Common Stock then issuable upon its conversion
into Common Stock. The Series [C] Preferred would generally vote together with
the Common Stock on all matters submitted to a vote of stockholders and not as a
separate class, except as provided below.
Protective Provisions: Consent of the holders of at least [a majority/66 2/3%]
of the outstanding Series [C] Preferred, voting separately as a class, would be
required for: (1) any amendment or change to the rights, preferences, privileges
or powers of, or the restrictions provided for the benefit of, the Series [C]
Preferred; (2) any action that authorizes, creates or issues shares of any class
of stock having preferences superior to or on a parity with the Series [C]
Preferred; (3) any action that reclassifies any outstanding shares into shares
having preferences or priority as to dividends or assets senior to or on a
parity with the preference of the Series [C] Preferred; (4) any amendment of the
Company's Certificate of Incorporation that adversely affects the rights of the
Series [C] Preferred; (5) any merger, consolidation, acquisition or similar
transaction or series of transactions, of the Company with one or more other
corporations in which the stockholders of the Company prior to such transaction
or series of transactions, would hold stock representing less than a majority of
the voting power of the outstanding stock of the surviving corporation
immediately after such transaction or series of transactions; (6) the sale of
all or substantially all the Company's assets; (7) the liquidation or
dissolution of the Company; (8) the declaration or payment of a dividend on the
Common Stock (other than a dividend payable solely in shares of Common Stock) or
the redemption or repurchase of any securities, other than repurchases following
termination of employment at the original purchase price therefor; (9 ) any
increase in the authorized number of or the issuance of any additional shares of
Common Stock or Preferred Stock; or (10) any increase or decrease in the
authorized number of directors of the Company.[Note: Issuers typically prefer that protective provisions be subject to a
vote of all classes of preferred voting together as a single class, which would
have the effect of diluting the new round's power to determine the outcome of
any vote on these issues.]
Terms of the Stock Purchase Agreement and Rights Agreement: The purchase of
shares of Series [C] Preferred would be made pursuant to a Stock Purchase
Agreement and a Registration Rights Agreement reasonably acceptable to the
Company and investors, which agreement would contain, among other things,
customary representations and warranties of the Company, covenants of the
Company reflecting the provisions set forth herein, and appropriate conditions
of closing, including, an opinion of counsel for the Company.
Board of Directors: The Company's Certificate of Incorporation and bylaws would
provide for a Board of Directors consisting of [insert number] members. The
number of directors could not be changed except by an amendment to such charter
documents approved by a vote of the Series [C] Preferred in accordance with the
Protective Provisions described above. In addition, the investor would have the
right to appoint a representative to attend all meetings of the Board and
committees thereof as an observer. On and after the Closing Date, the Board of Directors would consist of
[__________, __________ and __________].
[Note: This Term Sheet contemplates an observer right and not a right to
appoint a director. Many strategic corporate investors will not, as a matter of
policy, want an actual Board seat, preferring an observer right. They are
concerned about a variety of fiduciary obligations that apply to directors under
state corporation statutes. In July 2000, Delaware adopted a statute permitting
disclaimer of the "corporate opportunity" doctrine by companies by including
language to that effect in the Certificate of Incorporation. The corporate
opportunity doctrine, developed by case law not by statute, stands for the
proposition that opportunities that a director receives in his or her capacity
as a director of a company must be offered to the company. Although the new
statute may alleviate one of the fiduciary-related concerns, there are other
fiduciary duties as well, such as what should a director do when the stockholder
he or she represents has different interests than other stockholders.]
Use of Proceeds: The Company intends to use the proceeds from the Series [C]
Preferred Financing for working capital and general corporate purposes.
Rights of First Offer: Each holder of Series [C] Preferred would have a right of
first offer to purchase up to its pro rata share (based on such holder's
percentage of the Company's outstanding common shares, calculated on a fully
diluted, as-converted basis) of any equity securities offered by the Company,
other than: (1) securities issued in a transaction registered under the
Securities Act of 1933; and (2) securities issued in any of the circumstances
described in Clauses (1) through (5) under "Antidilution Provisions" above. The
holder would be entitled to purchase such securities at the same price and terms
and on the same conditions as the Company offers such securities to other
potential investors (with a right of oversubscription if any holder of Series
[C] Preferred elected not to purchase its pro rata share). This right would not
apply to and would terminate upon the closing of a Qualified IPO. [Any holder
who does not exercise his or her right in full with respect to an issuance of
securities would lose that right in connection with future issuances.Rights of first offer are also sometimes called preemptive rights. This
provision allows investors to (1) purchase all or any portion of the new
securities being offered on a pro rata basis (a "full gobble up") and (2) elect
to purchase any shares not subscribed for by other existing investors. "Full
gobble up" provisions are fairly rare and over-allotment elections are also
unusual because they delay closings. Normally, rights of first offer only allow
investors to purchase a portion of the securities to enable them to maintain
their percentage ownership in the company. By setting up the preemptive rights
in that manner, the Company can bring in new investors.
Right of First Refusal and Co-Sale Agreement: The Company, each holder of Series
[C] Preferred, the founders of the Company (the "Founders") and [insert other
key stockholders ("Other Stockholders")] would enter into a Co-Sale Agreement
that would give the holders of the Series [C] Preferred first refusal rights and
co-sale rights providing that any Founder [or Other Stockholder] who proposes to
sell all or a portion of such person's shares to a third party must permit the
holders of the Series [C] Preferred hereunder at their option (1) to purchase
such stock on the same terms as the proposed transferee, or (2) sell a
proportionate part of their shares on the same terms offered by the proposed
transferee. This right would terminate upon the closing of a Qualified IPO.
Information Rights: So long as shares of Series [C] Preferred are outstanding,
the Company would deliver to each holder: (1) audited annual financial
statements within ninety (90) days after the end of each fiscal year; (2)
unaudited quarterly financial statements within forty-five (45) days of the end
of each fiscal quarter; and (3) an annual operating budget and strategic plan
within thirty (30) days prior to the end of each fiscal year. For so long as
shares of Series [C] Preferred are outstanding, such holders would have standard
inspection rights. These information and inspection rights would terminate upon
the Company's Qualified Public Offering.
Registration Rights:
(1) Demand, S-3 and Piggyback Rights: The holders of Series [C] Preferred
would have registration rights customary in financings of this nature. The
specific terms of such registration rights would include at least the following:
(1) beginning at any time after the earlier of the [insert number] anniversary
of the closing of the Series [C] Preferred round or six months after the
Company's initial public offering, [one/two/three] demand registrations upon
request of holders of at least [insert %] of the registrable securities and
covering the registration of capital stock having an aggregate offering price in
excess of at least $[insert amount] million; (2) unlimited registrations on Form
S-3 assuming that each such registered offering has an aggregate offering price
of not less than $ [insert amount] million; (3) unlimited piggyback
registrations in connection with registrations of shares for the account of the
Company or selling stockholders exercising demand rights; and (4) cut-back
provisions providing that registrations must, other than in the Qualified IPO,
include at least [insert %] of the shares requested to be included by the
holders of registrable securities. [Officers, directors, founders, other
employees of the Company and consultants would be cut back in their entirety
before the holders of registrable securities would be cut back.]
(2) Expenses: The Company would bear the registration expenses (excluding
underwriting discounts and commissions, but including all other expenses related
to the registration) of all such demand, piggyback and S-3 registrations.
(3) Transfer of Rights: The registration rights may be transferred.
(4) Termination: The registration rights would not apply to any holder who
can sell all of such holder's shares in any three-month period without
registration pursuant to Rule 144 promulgated under the Securities Act of 1933.
(5) Additional Registration Rights: The Company would not grant
registration rights to any other holder of the Company's securities superior to
[or on parity with] the rights granted to the holders of the Series [C]
Preferred without the prior approval of a majority of the Series [C] Preferred.
(6) Market Stand-Off: The holders of Series [C] Preferred would agree not
to sell shares of any Common Stock or other capital stock for one hundred eighty
(180) days following the Company's initial public offering, so long as all
directors, officers and 1 % stockholders entered into similar agreements. [The
holders of Series [C] Preferred would have the right to be released pro rata
from such agreement in the event the underwriters released any other
stockholders from similar agreements.]
Confidentiality: The terms and conditions of the financing, including its
existence, would be confidential information and would not be disclosed to any
third party by the Company, except as provided below. The Company would be able
to disclose the existence of the financing, as well as each investor's
investment in the Company, solely to the Company's investors, investment
bankers, lenders, accountants, legal counsel, business partners, and bona fide
prospective investors, employees, lenders and business partners in each case
only where such persons or entities were under appropriate nondisclosure obligations.
Confidential Information and Invention Assignment Agreement: Each officer and
[key] employee of the Company would have entered into an acceptable confidential
information and invention assignment agreement. [The Company would use its best
efforts to have the remainder of the employees and officers sign such an agreement.]
Legal Fees: The Company would pay at the closing the fees and expenses of one
counsel for the investor (not to exceed $__________) arising in connection with
the transactions contemplated by this Term Sheet.
Employee Vesting: Stock issued to employees directors and consultants would be
subject to vesting/repurchase over four years. [At least [50%] of each founder's
shares would be subject to four years of vesting. Each of the founders would
execute a stock restriction agreement covering the shares held by such founder
providing that any unvested shares may be repurchased by the Company for the
original issue price in the event the employment of such founder is terminated.
Founder shares would vote as if fully vested for each founder remaining employed
by the Company.]
Governing Law: Delaware law.
Capitalization: After the closing of the Series [C] Preferred round, the
capitalization of the Company would be as follows:
[Insert capitalization table.]